2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow MG1113: new trials by email Literature Review of MG1113 trials Research Report on MG1113
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia Patient MG1113 - Hemophilia | Phase 1 | Completed | GC Biopharma Corp | 15 | 2022-08-24 | 2025-11-24 |
| A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients MG1113, Placebo of MG1113 - Hemophilia | Phase 1 | Completed | Green Cross Corporation | 41 | 2019-01-21 | 2021-10-26 |
Hemophilia A (2)
GC Biopharma Corp (1) · Green Cross Corporation (1)
South Korea (2)
Eun-Jin Choi (1) · Ji-Young Park, MD (1)